C50.911 ICD-10-CM Code: Malignant neoplasm of unspecified site of right female breast
Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.
Coding at a Glance
- Tabular directives
- 3 inclusion terms · 1 Excludes1 · 1 use-additional code
Inpatient Payment Groups (MS-DRG)
Potential MS-DRG participation — not a DRG assignment.
MS-DRGs this diagnosis helps define, as principal or secondary, per the CMS ICD-10-CM/PCS MS-DRG Definitions Manual v43, Appendix B.
- MS-DRG 582 — MASTECTOMY FOR MALIGNANCY WITH CC/MCC (MDC 09)
- MS-DRG 583 — MASTECTOMY FOR MALIGNANCY WITHOUT CC/MCC (MDC 09)
- MS-DRG 597 — MALIGNANT BREAST DISORDERS WITH MCC (MDC 09)
- MS-DRG 598 — MALIGNANT BREAST DISORDERS WITH CC (MDC 09)
- MS-DRG 599 — MALIGNANT BREAST DISORDERS WITHOUT CC/MCC (MDC 09)
A diagnosis appearing in a group's logic does not by itself determine the DRG assigned to a stay; the grouper uses the full claim.
Risk Adjustment (CMS-HCC)
Payment categories this diagnosis maps to under CMS-HCC V28, payment year 2026.
- HCC 23 — Prostate, Breast, and Other Cancers and Tumors
Other models: CMS-HCC V22 HCC 12 · RxHCC V08 HCC 22
Risk scores depend on the enrollee's full accepted diagnosis set and segment; a category mapping alone does not determine payment.
Coding instructions
Official Tabular Instructional Notes: the inclusion, exclusion and sequencing notes published for C50.911 in the official ICD-10-CM tabular list, quoted as published.
Notes without a marker are published on C50.911 itself; “inherited from” names the category or block whose note applies here.
Includes
Conditions the official ICD-10-CM tabular list includes under this code.
- connective tissue of breast
- Paget's disease of breast
- Paget's disease of nipple
Source: inherited from C50
Excludes1 — Not Coded Here
Conditions generally not reported together with this code (Excludes1) -- an error unless the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).
- skin of breast (C44.501, C44.511, C44.521, C44.591) Compare C50.911 vs C44.501 →
Source: inherited from C50
Use Additional Code
Supplementary codes the tabular list directs you to add.
- Use additional code to identify estrogen, and other hormones and factors receptor status (Z17.-)
Source: inherited from C50
Code Overview
MedCoder summary Summary composed by MedCoder from this code's official ICD-10-CM record. The tabular instructional notes themselves appear verbatim below.
Neoplasm Table Sites (1)
Anatomical sites from the official ICD-10-CM Table of Neoplasms that map to this code, with the matching behavior column.
- Neoplasm, neoplastic, breast (connective tissue) (glandular tissue) (soft parts) — Malignant, Primary
Decision Points
The directives on this code's own record, as a pre-claim checklist.
- Laterality is coded in this family. Confirm the documented side matches the code — the opposite-side siblings are in the relationships section. See the opposite-side sibling codes
- 1 Use Additional Code instruction — report the named additional code(s) when the documentation supports them. See the Use Additional Code notes
- 1 Excludes1 entry — codes named there are generally not reported together with this code (Guidelines I.A.12.a). See the Excludes1 notes
Checklist rows are derived from this code's own official directives; the wording of each check is MedCoder editorial. The official notes themselves are in the sections each row links to.
Verify Before Coding
- No Medicare Code Editor or MS-DRG Definitions Manual restrictions apply to this code.
From the code registry, the Medicare Code Editor, and the MS-DRG Definitions Manual. Check it against a full claim in Claim Check.
Relationships & Classification
Other codes that name C50.911 or its code family, from the CMS ICD-10-CM tabular instructional notes, the CMS Table of Neoplasms and the CMS Table of Neoplasms (site match derived from the code title). Tabular-note edges are stored at the code family level that carries each note.
Referenced by 3 Excludes1 notes: C49 — Malignant neoplasm of other connective and soft tissue (via C50.-), C49.3 — Malignant neoplasm of connective and soft tissue of thorax (via C50.-), D05 — Carcinoma in situ of breast (via C50.-).
These codes’ tabular lists mark this diagnosis as mutually exclusive — not reported together unless the conditions are documented as unrelated.
Referenced by 3 Code First instructions across 2 chapters: D75.81 — Myelofibrosis (via C50.-), Z17 — Estrogen, and other hormones and factors receptor status (via C50.-), Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels (via C50.-).
Each of these codes carries a Code First note naming this condition — when that code is reported, THIS code is sequenced first, ahead of it.
Referenced by 1 Code Also instruction: D61.82 — Myelophthisis (via C50.-).
These codes suggest coding this condition alongside when both are present.
Referenced by 5 Same-site neoplasm codes: C79.81 — Secondary malignant neoplasm of breast (via C50.9.-)Compare C50.911 vs C79.81 →, D05 — Carcinoma in situ of breast (via C50.9.-)Compare C50.911 vs D05 →, D24 — Benign neoplasm of breast (via C50.9.-)Compare C50.911 vs D24 →, D48.6 — Neoplasm of uncertain behavior of breast (via C50.9.-)Compare C50.911 vs D48.6 →, D49.3 — Neoplasm of unspecified behavior of breast (via C50.9.-)Compare C50.911 vs D49.3 →.
These codes represent related neoplasm behaviors affecting the same anatomic site.
Referenced by 5 Screening & history codes: Z12.3 — Encounter for screening for malignant neoplasm of breast (via C50.9.-)Compare C50.911 vs Z12.3 →, Z12.31 — Encounter for screening mammogram for malignant neoplasm of breast (via C50.9.-)Compare C50.911 vs Z12.31 →, Z12.39 — Encounter for other screening for malignant neoplasm of breast (via C50.9.-)Compare C50.911 vs Z12.39 →, Z80.3 — Family history of malignant neoplasm of breast (via C50.9.-)Compare C50.911 vs Z80.3 →, Z85.3 — Personal history of malignant neoplasm of breast (via C50.9.-)Compare C50.911 vs Z85.3 →.
These codes represent screening tests and history codes that refer to this active disease condition.
MS-DRG Grouper Relationships (FY2026)
Not on the CMS CC/MCC list — as a secondary diagnosis this code does not change MS-DRG severity.
Potential MS-DRG participation — not a DRG assignment.
Named in the grouper logic of 5 MS-DRGs: DRG 582 (MDC 09), DRG 583 (MDC 09), DRG 597 (MDC 09), DRG 598 (MDC 09), DRG 599 (MDC 09).
From the CMS MS-DRG Definitions Manual (Appendices B and C). Actual DRG assignment depends on the complete claim.
Clinical classification (AHRQ CCSR):NEO030 — Breast cancer - all other types (default).
Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses. Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality.
Related Codes
Same condition, opposite side
Same category and title, differing only in which side of the body is affected.
C50.912 — Malignant neoplasm of unspecified site of left female breast (left)Compare C50.911 vs C50.912 →, C50.919 — Malignant neoplasm of unspecified site of unspecified female breast (unspecified)Compare C50.911 vs C50.919 →
Same CMS-HCC risk category (V28)
CMS maps these diagnoses to the same Hierarchical Condition Category (Prostate, Breast, and Other Cancers and Tumors) for risk-adjusted payment.
C50.619 — Malignant neoplasm of axillary tail of unspecified female breast, C50.621 — Malignant neoplasm of axillary tail of right male breast, C50.622 — Malignant neoplasm of axillary tail of left male breast, C50.629 — Malignant neoplasm of axillary tail of unspecified male breast, C50.811 — Malignant neoplasm of overlapping sites of right female breast, C50.812 — Malignant neoplasm of overlapping sites of left female breast, C50.819 — Malignant neoplasm of overlapping sites of unspecified female breast, C50.821 — Malignant neoplasm of overlapping sites of right male breast, C50.822 — Malignant neoplasm of overlapping sites of left male breast, C50.829 — Malignant neoplasm of overlapping sites of unspecified male breast, C50.912 — Malignant neoplasm of unspecified site of left female breast, C50.919 — Malignant neoplasm of unspecified site of unspecified female breast, C50.921 — Malignant neoplasm of unspecified site of right male breast, C50.922 — Malignant neoplasm of unspecified site of left male breast, C50.929 — Malignant neoplasm of unspecified site of unspecified male breast, C50.A0 — Malignant inflammatory neoplasm of unspecified breast, C50.A1 — Malignant inflammatory neoplasm of right breast, C50.A2 — Malignant inflammatory neoplasm of left breast, C54.0 — Malignant neoplasm of isthmus uteri, C54.1 — Malignant neoplasm of endometrium, +213 more
Related risk categories
These categories interact through CMS's HCC hierarchy — one can suppress the other's risk-adjustment weight when both are present on a claim.
Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic, Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid, Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers, Lung and Other Severe Cancers, Lymphoma and Other Cancers, Bladder, Colorectal, and Other Cancers
Same clinical category (CCSR)
AHRQ's Clinical Classifications Software groups these diagnoses under the same clinical category (Breast cancer - all other types).
C50.619 — Malignant neoplasm of axillary tail of unspecified female breast, C50.621 — Malignant neoplasm of axillary tail of right male breast, C50.622 — Malignant neoplasm of axillary tail of left male breast, C50.629 — Malignant neoplasm of axillary tail of unspecified male breast, C50.811 — Malignant neoplasm of overlapping sites of right female breast, C50.812 — Malignant neoplasm of overlapping sites of left female breast, C50.819 — Malignant neoplasm of overlapping sites of unspecified female breast, C50.821 — Malignant neoplasm of overlapping sites of right male breast, C50.822 — Malignant neoplasm of overlapping sites of left male breast, C50.829 — Malignant neoplasm of overlapping sites of unspecified male breast, C50.912 — Malignant neoplasm of unspecified site of left female breast, C50.919 — Malignant neoplasm of unspecified site of unspecified female breast, C50.921 — Malignant neoplasm of unspecified site of right male breast, C50.922 — Malignant neoplasm of unspecified site of left male breast, C50.929 — Malignant neoplasm of unspecified site of unspecified male breast, C50.A0 — Malignant inflammatory neoplasm of unspecified breast, C50.A1 — Malignant inflammatory neoplasm of right breast, C50.A2 — Malignant inflammatory neoplasm of left breast, D05.00 — Lobular carcinoma in situ of unspecified breast, D05.01 — Lobular carcinoma in situ of right breast, +45 more
Same Index main term, other category
The ICD-10-CM Index to Diseases and Injuries files this code under the main terms “Carcinoma”, “Cancer”, “Adenocarcinoma”, …; these codes share that main term but sit in a different category of the Tabular List.
C4A.31 — Merkel cell carcinoma of nose (Merkel cell, nose), C4A.39 — Merkel cell carcinoma of other parts of face (Merkel cell, face, specified NEC), C4A.4 — Merkel cell carcinoma of scalp and neck (Merkel cell, neck), C4A.51 — Merkel cell carcinoma of anal skin (Merkel cell, anal skin), C4A.52 — Merkel cell carcinoma of skin of breast (Merkel cell, skin of breast), C4A.59 — Merkel cell carcinoma of other part of trunk (Merkel cell, trunk NEC), C4A.6 — Merkel cell carcinoma of upper limb, including shoulder (Merkel cell, shoulder), C4A.7 — Merkel cell carcinoma of lower limb, including hip (Merkel cell, hip), C4A.8 — Merkel cell carcinoma of overlapping sites (Merkel cell, overlapping sites), C4A.9 — Merkel cell carcinoma, unspecified (Merkel cell), C53.9 — Malignant neoplasm of cervix uteri, unspecified (solid, microinvasive, unspecified site), C56 — Malignant neoplasm of ovary (granulosa cell), C56.9 — Malignant neoplasm of unspecified ovary (ovarian), C58 — Malignant neoplasm of placenta (chorionic, unspecified site, female), C61 — Malignant neoplasm of prostate (duct, unspecified site, male), C62.90 — Malignant neoplasm of unspecified testis, unspecified whether descended or undescended (Sertoli cell, unspecified site), C64 — Malignant neoplasm of kidney, except renal pelvis (renal cell), C73 — Malignant neoplasm of thyroid gland (Hurthle cell), C74.0 — Malignant neoplasm of cortex of adrenal gland (adrenal cortical), C75.0 — Malignant neoplasm of parathyroid gland (water-clear cell), +36 more
Lab tests where this diagnosis supports Medicare coverage (NCD)
Medicare's National Coverage Determination (NCD) program lists this diagnosis as medical justification for these lab tests.
Contextual Map
Every relationship of C50.911 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Run C50.911 with these 7 related codes in Claim Check
Hierarchy
- C00-D49 — Chapter 2: Neoplasms (C00-D49) (C00-D49)[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- C00-C75 — Malignant neoplasms, stated or presumed to be primary (of specified sites), and certain specified histologies, except neuroendocrine, and of lymphoid, hematopoietic and related tissue[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
Referenced by Excludes1 notes
- C49 — Malignant neoplasm of other connective and soft tissue[Excludes1](via C50.-): “malignant neoplasm of connective tissue of breast (C50.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- C49.3 — Malignant neoplasm of connective and soft tissue of thorax[Excludes1](via C50.-): “malignant neoplasm of breast (C50.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D05 — Carcinoma in situ of breast[Excludes1](via C50.-): “Paget's disease of breast or nipple (C50.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
Referenced by Code First instructions
- D75.81 — Myelofibrosis[Code First](via C50.-): “malignant neoplasm of breast (C50.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- Z17 — Estrogen, and other hormones and factors receptor status[Code First](via C50.-): “malignant neoplasm of breast (C50.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels[Code First](via C50.-): “malignant neoplasm of breast (C50.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
Referenced by Code Also instructions
- D61.82 — Myelophthisis[Code Also](via C50.-): “malignant neoplasm of breast (C50.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
Referenced by Same-site neoplasm codes
- C79.81 — Secondary malignant neoplasm of breast[Same site](via C50.9.-): “Same site — primary malignancy (breast)”— CMS Table of Neoplasms · icd10cm-fy2026
- D05 — Carcinoma in situ of breast[Same site](via C50.9.-): “Same site — primary malignancy (breast)”— CMS Table of Neoplasms · icd10cm-fy2026
- D24 — Benign neoplasm of breast[Same site](via C50.9.-): “Same site — primary malignancy (breast)”— CMS Table of Neoplasms · icd10cm-fy2026
- D48.6 — Neoplasm of uncertain behavior of breast[Same site](via C50.9.-): “Same site — primary malignancy (breast)”— CMS Table of Neoplasms · icd10cm-fy2026
- D49.3 — Neoplasm of unspecified behavior of breast[Same site](via C50.9.-): “Same site — primary malignancy (breast)”— CMS Table of Neoplasms · icd10cm-fy2026
Referenced by Screening & history codes MedCoder-derived
- Z12.3 — Encounter for screening for malignant neoplasm of breast[Lifecycle](via C50.9.-): “Active disease for this site (breast)”— CMS Table of Neoplasms (site match derived from the code title) · icd10cm-fy2026
- Z12.31 — Encounter for screening mammogram for malignant neoplasm of breast[Lifecycle](via C50.9.-): “Active disease for this site (breast)”— CMS Table of Neoplasms (site match derived from the code title) · icd10cm-fy2026
- Z12.39 — Encounter for other screening for malignant neoplasm of breast[Lifecycle](via C50.9.-): “Active disease for this site (breast)”— CMS Table of Neoplasms (site match derived from the code title) · icd10cm-fy2026
- Z80.3 — Family history of malignant neoplasm of breast[Lifecycle](via C50.9.-): “Active disease for this site (breast)”— CMS Table of Neoplasms (site match derived from the code title) · icd10cm-fy2026
- Z85.3 — Personal history of malignant neoplasm of breast[Lifecycle](via C50.9.-): “Active disease for this site (breast)”— CMS Table of Neoplasms (site match derived from the code title) · icd10cm-fy2026
Clinical classification (CCSR)
- NEO030 — Breast cancer - all other types[CCSR]— AHRQ CCSR for ICD-10-CM Diagnoses (HCUP)
Risk adjustment (CMS-HCC)
- HCC 23 — Prostate, Breast, and Other Cancers and Tumors [CMS-HCC]— CMS-HCC V28 · 2026
MS-DRG Grouper
- DRG 582 — MASTECTOMY FOR MALIGNANCY WITH CC/MCC[MS-DRG]: “MASTECTOMY FOR MALIGNANCY WITH CC/MCC (MDC 09)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
- DRG 583 — MASTECTOMY FOR MALIGNANCY WITHOUT CC/MCC[MS-DRG]: “MASTECTOMY FOR MALIGNANCY WITHOUT CC/MCC (MDC 09)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
- DRG 597 — MALIGNANT BREAST DISORDERS WITH MCC[MS-DRG]: “MALIGNANT BREAST DISORDERS WITH MCC (MDC 09)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
- DRG 598 — MALIGNANT BREAST DISORDERS WITH CC[MS-DRG]: “MALIGNANT BREAST DISORDERS WITH CC (MDC 09)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
- DRG 599 — MALIGNANT BREAST DISORDERS WITHOUT CC/MCC[MS-DRG]: “MALIGNANT BREAST DISORDERS WITHOUT CC/MCC (MDC 09)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
MDC crossing
- MDC 09 — Diseases and Disorders of the Skin, Subcutaneous Tissue and Breast[MDC crossing]: “Diseases and Disorders of the Skin, Subcutaneous Tissue and Breast — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs. 7,376 same-MDC procedures group here; browse them on the MDC page.”— CMS MS-DRG Definitions Manual · FY2026
Neoplasm sites
- Neoplasm, neoplastic, breast (connective tissue) (glandular tissue) (soft parts) — Neoplasm, neoplastic, breast (connective tissue) (glandular tissue) (soft parts) — Malignant, Primary [Neoplasm table]: “Neoplasm, neoplastic, breast (connective tissue) (glandular tissue) (soft parts) (Malignant, Primary)”— CMS Table of Neoplasms · icd10cm-fy2026
Nearest codes (40)
- C50 — Malignant neoplasm of breast[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- C50.429 — Malignant neoplasm of upper-outer quadrant of unspecified male breast[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- C50.5 — Malignant neoplasm of lower-outer quadrant of breast[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- C50.51 — Malignant neoplasm of lower-outer quadrant of breast, female[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- C50.511 — Malignant neoplasm of lower-outer quadrant of right female breast[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- C50.512 — Malignant neoplasm of lower-outer quadrant of left female breast[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- C50.519 — Malignant neoplasm of lower-outer quadrant of unspecified female breast[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- C50.52 — Malignant neoplasm of lower-outer quadrant of breast, male[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- and 32 more
Change history
- FY2016 — In the code set at ICD-10-CM adoption [Change history]— CMS release files (code change ledger) · icd10cm-fy2016
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, title, tabular notes and index terms Official source data
- CMS/CDC ICD-10-CM FY2026 tabular list, index and tables, effective October 1, 2025 Release, file and checksum · Publisher’s page
- Claim edits Official source data
- CMS Definitions of Medicare Code Edits — v43.1 (April 2026) Release, file and checksum · Publisher’s page
- Inpatient payment groups Official source data
- CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v43 Release, file and checksum · Publisher’s page
- Risk adjustment Official source data
- 2026 Mid-Year Final ICD-10 Mappings + Model Software (cms.gov/files/zip/2026-midyear-final-icd-10-mappings.zip, 2026-midyear-final-model-software.zip) — CMS-HCC V28, PY2026 mid-year final release Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS ICD-10-CM release addenda, ingested release by release into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder structured relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates
Change history
- FY2016 — October 1, 2015In the code set at ICD-10-CM adoptionMalignant neoplasm of unspecified site of right female breast
No changes since FY2016 — additions, deletions, description changes and billable-status changes are tracked through FY2027 (effective October 1, 2026), and none are recorded for this code. Note changes are tracked from FY2027 only.
Nearest Codes in This Family
Official ICD-10-CM classifications closest to C50.911 in its code family, with their registry titles.
- C50.821 — Malignant neoplasm of overlapping sites of right male breast
- C50.822 — Malignant neoplasm of overlapping sites of left male breast
- C50.829 — Malignant neoplasm of overlapping sites of unspecified male breast
- C50.9 — Malignant neoplasm of breast of unspecified site
- C50.91 — Malignant neoplasm of breast of unspecified site, female
- C50.912 — Malignant neoplasm of unspecified site of left female breast
- C50.919 — Malignant neoplasm of unspecified site of unspecified female breast
- C50.92 — Malignant neoplasm of breast of unspecified site, male
- C50.921 — Malignant neoplasm of unspecified site of right male breast
- C50.922 — Malignant neoplasm of unspecified site of left male breast